The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Andres Jan Schrader

Department of Urology

Ulm University

Ulm 89075

Germany; E-Mails: (A.J.S.); (M.S.); (M.V.C.) ; Department of Physiology

Germany; E-Mails: (B.N.); (M.H.)

[email]@gmx.de

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Urology, Ulm University, Ulm 89075, Germany; E-Mails: (A.J.S.); (M.S.); (M.V.C.) ; Department of Physiology, Germany; E-Mails: (B.N.); (M.H.). 2012
  • Department of Urology, Philipps-University Medical School, Baldingerstrasse, 35043 Marburg, Germany. 2003 - 2009
  • Department of Cell Biology, Immunology and Experimental Oncology, National Research Centre for Biotechnology (GBF), Braunschweig, Germany. 2000

References

  1. Effects of sorafenib on C-terminally truncated androgen receptor variants in human prostate cancer cells. Zengerling, F., Streicher, W., Schrader, A.J., Schrader, M., Nitzsche, B., Cronauer, M.V., Höpfner, M. Int. J. Mol. Sci (2012) [Pubmed]
  2. Overweight is associated with improved cancer-specific survival in patients with organ-confined renal cell carcinoma. Schrader, A.J., Rustemeier, J., Rustemeier, J.C., Timmesfeld, N., Varga, Z., Hegele, A., Olbert, P.J., Hofmann, R. J. Cancer Res. Clin. Oncol. (2009) [Pubmed]
  3. Urinary collecting system invasion in renal cell carcinoma: incidence and long-term prognosis. Schrader, A.J., Rustemeier, J., Varga, Z., Hegele, A., Olbert, P.J., Frohme, C., Hofmann, R. Int. J. Urol. (2009) [Pubmed]
  4. Incidence and long-term prognosis of papillary renal cell carcinoma. Schrader, A.J., Rauer-Bruening, S., Olbert, P.J., Hegele, A., Rustemeier, J., Timmesfeld, N., Varga, Z., Hofmann, R. J. Cancer Res. Clin. Oncol. (2009) [Pubmed]
  5. Metastatic non-clear cell renal cell carcinoma: current therapeutic options. Schrader, A.J., Olbert, P.J., Hegele, A., Varga, Z., Hofmann, R. BJU Int. (2008) [Pubmed]
  6. Metastatic renal cell carcinoma: recent advances and current therapeutic options. Schrader, A.J., Hofmann, R. Anticancer. Drugs (2008) [Pubmed]
  7. Clinical impact of MDR1-expression in testicular germ cell cancer. Schrader, A.J., Seger, M., Konrad, L., Olbert, P., Hegele, A., Hofmann, R., Heidenreich, A. Exp. Oncol. (2007) [Pubmed]
  8. Second-line strategies for metastatic renal cell carcinoma: classics and novel approaches. Schrader, A.J., Varga, Z., Hegele, A., Pfoertner, S., Olbert, P., Hofmann, R. J. Cancer Res. Clin. Oncol. (2006) [Pubmed]
  9. Treatment targeted at vascular endothelial growth factor: a promising approach to managing metastatic kidney cancer. Schrader, A.J., Varga, Z., Pfoertner, S., Goelden, U., Buer, J., Hofmann, R. BJU Int. (2006) [Pubmed]
  10. Application of thalidomide/interleukin-2 in immunochemotherapy-refractory metastatic renal cell carcinoma. Schrader, A.J., Heidenreich, A., Hegele, A., Olbert, P., Ohlmann, C.H., Varga, Z., von Knobloch, R., Hofmann, R. Anticancer. Drugs (2005) [Pubmed]
  11. Application of retinoids in the treatment of renal cell carcinoma--a futile effort?. Schrader, A.J., von Knobloch, R., Heidenreich, A., Buer, J., Hofmann, R. Anticancer. Drugs (2004) [Pubmed]
  12. Giant hydronephrosis mimicking progressive malignancy. Schrader, A.J., Anderer, G., von Knobloch, R., Heidenreich, A., Hofmann, R. BMC. Urol (2003) [Pubmed]
  13. Combined chemoimmunotherapy in metastatic melanoma--is there a need for the double?. Schrader, A.J. Anticancer. Drugs (2000) [Pubmed]
  14. Molecular and prognostic classification of advanced melanoma: a multi-marker microcontamination assay of peripheral blood stem cells. Schrader, A.J., Probst-Kepper, M., Grosse, J., Kunter, U., Schenk, F., Franzke, A., Atzpodien, J., Buer, J. Melanoma Res. (2000) [Pubmed]
  15. Tumour microdissemination and survival in metastatic melanoma. Schrader, A.J., Probst-Kepper, M., Grosse, J., Kunter, U., Franzke, A., Sel, S., Atzpodien, E., Buer, J. Anticancer Res. (2000) [Pubmed]
 
WikiGenes - Universities